Amphastar Pharmaceuticals AMPH Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 49.5%-1.6pp | 51.1%-3.4pp | 54.5%+4.6pp | 49.9%+4.2pp | |
| Operating margin | 19.5%-8.6pp | 28.1%-2.5pp | 30.6%+9.0pp | 21.5%+5.6pp | |
| Net margin | 13.6%-8.2pp | 21.8%+0.4pp | 21.3%+3.0pp | 18.3%+4.1pp | |
| Efficiency | |||||
| Asset turnover | 0.4×0.0× | 0.5×-0.1× | 0.6×-0.1× | 0.7×0.0× | |
| Liquidity | |||||
| Current ratio | 4×+0.9× | 3.1×+0.9× | 2.2×-1.8× | 4×+0.9× | |
| Leverage | |||||
| Net debt / EBITDA | 2.5×+0.5× | 1.9×-0.1× | 2×+2.4× | -0.4×-0.2× | |
| Valuation | |||||
| Market capitalization | $926.83M-19.9% | $1.79B-39.7% | $2.96B+119% | $1.35B+21.5% | |
| Price / earnings | 11.7×+3.5× | 11.2×-10.4× | 21.5×+6.7× | 14.8×-3.1× | |
| Price / sales | 1.3×-0.3× | 2.4×-2.2× | 4.6×+1.9× | 2.7×+0.2× | |
| EV / EBITDA | 8.3×+1.7× | 8.8×-5.8× | 14.6×+4.8× | 9.8×-1.9× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Amphastar Pharmaceuticals's profit margins?
- Amphastar Pharmaceuticals (AMPH) runs a 47.3% gross margin and a 16.2% operating margin, with a 11.0% net margin.
- Where do Amphastar Pharmaceuticals's ratios come from?
- Every ratio is computed from Amphastar Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
